Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists

ISSN： 1024-5332

Source： Hematology, Vol.14, Iss.1, 2009-02, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologists

By Reilly John T.

Hematology, Vol. 17, Iss. 4, 2012-07 ,pp. : 187-192

Maney Publishing

Access to resources Recommend Favorite

Anagrelide therapy in pregnancy: report of a case of essential thrombocythemia

By Doubek Michael

Annals of Hematology, Vol. 83, Iss. 11, 2004-11 ,pp. : 726-727

Springer Publishing Company

Access to resources Recommend Favorite

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis

By Silver Richard T Kiladjian Jean-Jacques Hasselbalch Hans Carl

Expert Review of Hematology, Vol. 6, Iss. 1, 2013-02 ,pp. : 49-58

Informa Healthcare

Access to resources Recommend Favorite

Bilateral adrenal hemorrhage in essential thrombocythemia

By Kojima K. Fujii N. Takata S. Tezen T. Morikawa T. Kaneda K. Takenaka K. Itoshima T. Tanimoto M.

Annals of Hematology, Vol. 81, Iss. 6, 2002-06 ,pp. : 350-351

Springer Publishing Company

Access to resources Recommend Favorite

Identification of differences in immunotherapy knowledge and practice patterns among oncologists from six European countries

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 269-274

Spandidos Publications

Access to resources Recommend Favorite